CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2018—Meridian Life Science added Zero-X-React Zika Envelope Rec-Antigen to its line of infectious diseases antigens and antibodies. Suitable for use in ELISA and lateral flow assays, this recombinant Zika envelope antigen is designed to eliminate cross-reactivity of the major conserved domain of all flaviviruses and reacts with IgG and IgM antibodies. The company also released high-performing renin monoclonal antibodies suitable for commercial ELISA tests.
Meridian Life Science, 901-382-8716